Historical replay
BRXSELL2024-03-11
Research evidence · Momentum state recorded
Real SEC and market data replayed in strict as-of order.
1. Executive summary
Insider activity activity in BRX was grouped into one SELL economic campaign (1 filing event, 1 insider, 1 source filing). Disclosed value about $239,039.5. Matured 30-day endpoint: +4.09% (win).
- 30-day outcome
- +4.09% · Positive
- 90-day outcome
- -7.07% · Negative
- Evidence type
- Historical replay
2. Event overview
- Ticker
- BRX
- Side
- SELL
- Campaign start
- 2024-03-11
- First filing
- 2024-03-08
- Entry session
- 2024-03-11
- Entry price (simulated)
- $22.7600
- Disclosed value
- $239,039.5
3. Insider activity
- Unique insiders
- 1
- Unique filings
- 1
4. Why the system flagged it
Observed facts
- Side: SELL
- Filing events in campaign: 1
- Disclosed value on record
- Momentum state: Momentum state recorded
Research interpretation
- Included in the strict historical replay universe after as-of reconstruction.
- Child filings support one economic exposure — they are not separate proof rows.
5. Campaign context
Multiple related filings are grouped into one economic campaign to avoid counting the same exposure repeatedly.
- Origin date
- 2024-03-11
- Filing events
- 1
- Unique insiders
- 1
- Unique filings
- 1
6. Timing and publication proof
Source accepted
2024-03-08
Replay decision / entry session
2024-03-11
Intended entry
Simulated T+1 @ $22.7600
Note
Historical replay — not original live VIP delivery.
7. Market path and outcome
For SELL research, a favourable move means price decline (direction-aware price path; not an executable short return).
30-day
+4.09% · Positive
90-day
-7.07% · Negative
Best move
+8.61%
Adverse move
-3.69%
- Reached +10 / +15 / +30
- N / N / N
- Touched −10 / −15
- N / N
- Exit policy
- TIME
Entry
2024-03-11
Best favourable point
MFE +8.61%
Worst adverse point
MAE -3.69%
30d endpoint
+4.09% · Positive
8. Risk and alternative interpretation
- This is historical replay research — not an original live VIP delivery.
- An insider sale may reflect diversification, tax, or portfolio management rather than a directional view.
9. Sources and evidence
- SEC accession on filing lineage
- Methodology
- Historical Evidence V2 · Released August 2026 · Coverage-limited replay
Verify this record
- Campaign reference
- CX:01866
- Acceptance
- Not available from the source.
- Origin research id
- —
Methodology and limitations
- Coverage-limited descriptive historical evidence.
- Not an executable portfolio return.
- SELL values are direction-aware price path, not short execution P&L.